Join Growin Stock Community!

安盛生6734.TW Overview

TW StockBiotech. & Medical
(No presentation for 6734)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

安盛生（6734）Overall Performance

安盛生（6734）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

安盛生（6734） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

安盛生（6734）Key Information

安盛生（6734）Profile

iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare. The company's PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management; and PixoTest COVID-19 Rapid Antigen Test for infectious disease management, as well as PixoHealth Pass Admin app and Web portal. The company was founded in 2012 and is based in Taipei, Taiwan.

安盛生（6734）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.66
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
6.35
PB Ratio
-
Price-to-FCF
248.99
METRIC
VALUE
vs. INDUSTRY
Gross Margin
26.31%
Net Margin
-237.42%
Revenue Growth (YoY)
-65.03%
Profit Growth (YoY)
-82.20%
3-Year Revenue Growth
20.78%
3-Year Profit Growth
186.75%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.66
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
6.35
PB Ratio
-
Price-to-FCF
248.99
Gross Margin
26.31%
Net Margin
-237.42%
Revenue Growth (YoY)
-65.03%
Profit Growth (YoY)
-82.20%
3-Year Revenue Growth
20.78%
3-Year Profit Growth
186.75%
default symbol

6734

安盛生

7.11D

-4.78%

(-0.05)

  • When is 6734's latest earnings report released?

    The most recent financial report for 安盛生 (6734) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6734's short-term business performance and financial health. For the latest updates on 6734's earnings releases, visit this page regularly.

  • How much cash does 6734 have?

    At the end of the period, 安盛生 (6734) held Total Cash and Cash Equivalents of 13.31M, accounting for 0.3 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6734 go with three margins increasing?

    In the latest report, 安盛生 (6734) did not achieve the “three margins increasing” benchmark, with a gross margin of 41.85%%, operating margin of -201.61%%, and net margin of -209.09%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6734's profit trajectory and future growth potential.